Deficient activation of CB95 (APO-1/Fas) mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma

U. Ramp, M. Dejosez, C. Mahotka, B. Czarnotta, T. Kalinski, M. Wenzel, I. Lorenz, M. Müller, P. Krammer, H. E. Gabbert, C. D. Gerharz

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Deficient activation of CB95 (APO-1/Fas) mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences